American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Tallman
    Tallman
  5. Perales
    Perales
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Kernan
    Kernan
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3858)
  2. Hematologic Malignancies, Division of (3654)
  3. Center for Hematologic Malignancies (3552)
  4. GSK Faculty (1554)
  5. Adult Leukemia (1293)
  6. Sloan Kettering Institute Faculty (1065)
  7. Bone Marrow Transplant (939)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (931)
  9. Lymphoma (902)
  10. Tow Center for Developmental Oncology (TCDO) (865)
Search Within
Formats
  1. Meeting Abstract (4152)
  2. Journal Article (1242)
  3. Research Letter (44)
  4. Review (44)
  5. Editorial (34)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3858)
  2. Hematologic Malignancies, Division of (3654)
  3. Center for Hematologic Malignancies (3552)
  4. GSK Faculty (1554)
  5. Adult Leukemia (1293)
  6. Sloan Kettering Institute Faculty (1065)

More Groups

People
  1. Sergio Giralt (337)
  2. Andrew Zelenetz (329)
  3. Ross Levine (312)
  4. Martin Tallman (298)
  5. Miguel-Angel Perales (294)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (46)
  2. 2024 (430)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5167)
  2. Blood Advances (322)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5539)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mis-Splicing Derived Neoantigens and Cognate T Cell Receptors in Splicing Factor Mutant Myeloid Neoplasms
    Meeting Abstract

    Kim, W. J.; Crosse, E. I.; De Neef, E.; Etxeberria, I.; Sabio, E.; Wang, E.; Bewersdorf, J. P.; Lu, S. X.; Belleville, A.; Fox, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Single-Agent Mosunetuzumab Produces High Complete Response Rates in Patients with Newly Diagnosed Follicular Lymphoma: Primary Analysis of the Mithic-FL1 Trial
    Meeting Abstract

    Falchi, L.; Okwali, M.; Lopes, A. F.; Hamlin, P. A.; Lue, J. K.; Ghione, P.; Owens, C.; Torka, P.; Kumar, A.; Steiner, R.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Fixed-Duration Epcoritamab + R2 Drives Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: 2-Year Follow-up from Arm 2 of the Epcore NHL-2 Trial
    Meeting Abstract

    Falchi, L.; Balari, A. S.; Leppä, S.; Vermaat, J. S. P.; Nijland, M.; Christensen, J. H.; de Vos, S.; Holte, H.; Merryman, R. W.; Lugtenburg, P.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Long-Term Follow up of a Prospective Pilot Study of an a/,8 T-Lymphocyte Depleted Graft Conditioned with a Reduced Intensity Regimen in Patients with Hematologic Malignancies
    Meeting Abstract

    Hughes, C. F.; Lin, R. J.; Devlin, S. M.; Shaffer, B. C.; Jakubowski, A. A.; Talla, V.; Saldia, A.; Gyurkocza, B.; Papadopoulos, E. B.; Giralt, S. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Increased Fiber Intake Results in Better Overall Survival and Lower GI-aGVHD in Allo-HCT Recipients and Pre-Clinical Gvhd Models
    Meeting Abstract

    Paredes, J.; Fei, T.; Dai, A. Q.; Ramos, R.; Adintori, P.; Kousa, A.; Nguyen, C. L.; Victor, K.; Ghale, R.; Pohl, C.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • TMPRSS6 Antisense Oligonucleotide Therapy Reverses Inflammation in Jak2V617F Mutant Mice
    Meeting Abstract

    Levy, M.; Li, H. H.; Dunbar, A.; Huang, Z. X.; Park, Y.; Lu, M.; Phattalung, P. N.; Planoutene, M.; Casu, C.; Rivella, S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Non-Driver Genomic Alterations and Venous Thromboembolism in Myeloproliferative Neoplasms
    Meeting Abstract

    Ajufo, H.; Leader, A.; Derkach, A.; Chrysafi, P.; Singh, R.; Rampal, R.; Mantha, S.; Zwicker, J. I.
    Blood (2024)

    Fulltext@MSK | Save
  • Delayed Trp53 Activation Protects Dnmt3a-Mutant Haematopoietic Stem Cells from Inflammatory Attrition
    Meeting Abstract

    Marando, L.; Giotopoulos, G.; Madrigal, P.; Azazi, D. M. A.; Asby, R.; Calleja-Cervantes, M. E.; Lara-Astiaso, D.; Wilson, N. K.; Hannah, R.; Bagri, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • BRUIN CLL-321: Randomized Phase III Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab (IdelaR) or Bendamustine Plus Rituximab (BR) in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Meeting Abstract

    Sharman, J. P.; Munir, T.; Grosicki, S.; Roeker, L.; Burke, J. M.; Chen, C.; Grzasko, N.; Follows, G.; Matrai, Z.; Sanna, A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Clonal Evolution of Lymphoid Malignancies Following the Mutagenic Impact of Radiotherapy
    Meeting Abstract

    Diamond, B.; Chahar, D.; Jain, M. D.; Poos, A. M.; Durante, M.; Ziccheddu, B.; Kaddoura, M.; Papadimitriou, M.; Maclachlan, K. H.; Jelinek, T.; more...
    Blood (2024)

    Fulltext@MSK | Save